Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,946,721
+$584,544 QoQ
Shares Held
15,684
+1.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#1,463
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stratos Wealth Advisors, LLC holds $23,629,551 across 10 Drug Manufacturers - General names. ABBV ranks #2 (16.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,874 | $5,846,022 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
15,684 | $3,946,721 | |
| 3 | MRK |
Merck & Co., Inc.
|
24,837 | $3,191,554 | |
| 4 | JNJ |
Johnson & Johnson
|
11,189 | $2,841,670 | |
| 5 | AMGN |
Amgen Inc
|
6,512 | $2,358,125 | |
| 6 | PFE |
Pfizer Inc
|
76,265 | $1,836,461 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
29,183 | $1,681,524 | |
| 8 | NVS |
Novartis AG
|
8,587 | $1,345,754 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,946,721 | 15,684 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,362,177 | 15,459 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $3,633,904 | 15,904 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $3,673,613 | 15,866 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,745,876 | 14,793 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $3,113,886 | 14,862 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $4,293,054 | 24,159 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $4,759,465 | 24,101 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $4,130,716 | 24,083 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $4,479,477 | 24,599 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $9,197,624 | 59,351 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $9,275,705 | 62,228 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $7,009,058 | 52,023 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $8,327,082 | 52,250 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $8,556,441 | 52,945 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $6,843,636 | 50,992 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $8,451,828 | 55,183 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $8,908,592 | 54,954 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $7,901,131 | 58,354 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $6,214,606 | 57,612 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $6,544,384 | 58,100 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $6,001,556 | 55,457 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $6,313,170 | 58,919 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $4,629,481 | 52,854 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $5,147,381 | 52,428 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $759,461 | 9,968 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||